Design and Synthesis of Sulfonamide‐Attached 2‐(Isoxazol‐3‐yl)‐1 H ‐imidazoles as Anticancer Agents
Library of 2‐(isoxazol‐3‐yl)‐1 H ‐imidazole sulfonamide derivatives (4 a‐j) has been synthesized and structures were confirmed by 1 HNMR, 13 CNMR and mass spectral analysis. Further these compounds were tested for their anticancer activity against four human cancer cell lines, such as MCF‐7 (breast...
Gespeichert in:
| Veröffentlicht in: | ChemistrySelect (Weinheim) 2020-07, Vol.5 (26), p.7919-7922 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 7922 |
|---|---|
| container_issue | 26 |
| container_start_page | 7919 |
| container_title | ChemistrySelect (Weinheim) |
| container_volume | 5 |
| creator | Dende, Satheesh Kumar Korupolu, Raghu Babu Leleti, Krishnakanth Reddy |
| description | Library of 2‐(isoxazol‐3‐yl)‐1
H
‐imidazole sulfonamide derivatives
(4 a‐j)
has been synthesized and structures were confirmed by
1
HNMR,
13
CNMR and mass spectral analysis. Further these compounds were tested for their anticancer activity against four human cancer cell lines, such as MCF‐7 (breast cancer), A549 (lung cancer), Colo‐205 (colon cancer) and A2780 (ovarian cancer) by MTT assay and etoposide used as positive control. Among them, compounds
4 b
,
4 c
,
4 d
,
4 e
,
4 g
,
4 h
and
4 i
showed more potent anticancer activity against human cancer cell lines. |
| doi_str_mv | 10.1002/slct.202001449 |
| format | Article |
| fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1002_slct_202001449</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1002_slct_202001449</sourcerecordid><originalsourceid>FETCH-LOGICAL-c849-55c8216b508bedb60065d54ca4da69852fe0f7355a4d60c54c5e61c902e3e8e73</originalsourceid><addsrcrecordid>eNpNULFOwzAQtRBIVKUrs0cYEs527CRjVKCtVImh3SPHubRBqY3iIBEmPoFv5EtwBEIMd--9e3c3PEKuGcQMgN_5zgwxBw7AkiQ_IzMulIyUTPLzf_ySLLx_hrCkMsVlOiPuHn17sFTbmu5GOxyD9NQ1dPfaNc7qU1vj18dnMQzaHLGmPIibjXdv-t11gYtQY3cbOqNrGqANF5OHnmpPCzu0RluDPS0OaAd_RS4a3Xlc_OKc7B8f9st1tH1abZbFNjJZkkdSmowzVUnIKqwrBaBkLROjk1qrPJO8QWhSIWUYKDDBkaiYyYGjwAxTMSfxz1vTO-97bMqXvj3pfiwZlFNg5RRY-ReY-AbskWRb</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Design and Synthesis of Sulfonamide‐Attached 2‐(Isoxazol‐3‐yl)‐1 H ‐imidazoles as Anticancer Agents</title><source>Wiley Online Library All Journals</source><creator>Dende, Satheesh Kumar ; Korupolu, Raghu Babu ; Leleti, Krishnakanth Reddy</creator><creatorcontrib>Dende, Satheesh Kumar ; Korupolu, Raghu Babu ; Leleti, Krishnakanth Reddy</creatorcontrib><description>Library of 2‐(isoxazol‐3‐yl)‐1
H
‐imidazole sulfonamide derivatives
(4 a‐j)
has been synthesized and structures were confirmed by
1
HNMR,
13
CNMR and mass spectral analysis. Further these compounds were tested for their anticancer activity against four human cancer cell lines, such as MCF‐7 (breast cancer), A549 (lung cancer), Colo‐205 (colon cancer) and A2780 (ovarian cancer) by MTT assay and etoposide used as positive control. Among them, compounds
4 b
,
4 c
,
4 d
,
4 e
,
4 g
,
4 h
and
4 i
showed more potent anticancer activity against human cancer cell lines.</description><identifier>ISSN: 2365-6549</identifier><identifier>EISSN: 2365-6549</identifier><identifier>DOI: 10.1002/slct.202001449</identifier><language>eng</language><ispartof>ChemistrySelect (Weinheim), 2020-07, Vol.5 (26), p.7919-7922</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c849-55c8216b508bedb60065d54ca4da69852fe0f7355a4d60c54c5e61c902e3e8e73</citedby><cites>FETCH-LOGICAL-c849-55c8216b508bedb60065d54ca4da69852fe0f7355a4d60c54c5e61c902e3e8e73</cites><orcidid>0000-0003-3051-9949</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Dende, Satheesh Kumar</creatorcontrib><creatorcontrib>Korupolu, Raghu Babu</creatorcontrib><creatorcontrib>Leleti, Krishnakanth Reddy</creatorcontrib><title>Design and Synthesis of Sulfonamide‐Attached 2‐(Isoxazol‐3‐yl)‐1 H ‐imidazoles as Anticancer Agents</title><title>ChemistrySelect (Weinheim)</title><description>Library of 2‐(isoxazol‐3‐yl)‐1
H
‐imidazole sulfonamide derivatives
(4 a‐j)
has been synthesized and structures were confirmed by
1
HNMR,
13
CNMR and mass spectral analysis. Further these compounds were tested for their anticancer activity against four human cancer cell lines, such as MCF‐7 (breast cancer), A549 (lung cancer), Colo‐205 (colon cancer) and A2780 (ovarian cancer) by MTT assay and etoposide used as positive control. Among them, compounds
4 b
,
4 c
,
4 d
,
4 e
,
4 g
,
4 h
and
4 i
showed more potent anticancer activity against human cancer cell lines.</description><issn>2365-6549</issn><issn>2365-6549</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNpNULFOwzAQtRBIVKUrs0cYEs527CRjVKCtVImh3SPHubRBqY3iIBEmPoFv5EtwBEIMd--9e3c3PEKuGcQMgN_5zgwxBw7AkiQ_IzMulIyUTPLzf_ySLLx_hrCkMsVlOiPuHn17sFTbmu5GOxyD9NQ1dPfaNc7qU1vj18dnMQzaHLGmPIibjXdv-t11gYtQY3cbOqNrGqANF5OHnmpPCzu0RluDPS0OaAd_RS4a3Xlc_OKc7B8f9st1tH1abZbFNjJZkkdSmowzVUnIKqwrBaBkLROjk1qrPJO8QWhSIWUYKDDBkaiYyYGjwAxTMSfxz1vTO-97bMqXvj3pfiwZlFNg5RRY-ReY-AbskWRb</recordid><startdate>20200715</startdate><enddate>20200715</enddate><creator>Dende, Satheesh Kumar</creator><creator>Korupolu, Raghu Babu</creator><creator>Leleti, Krishnakanth Reddy</creator><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0003-3051-9949</orcidid></search><sort><creationdate>20200715</creationdate><title>Design and Synthesis of Sulfonamide‐Attached 2‐(Isoxazol‐3‐yl)‐1 H ‐imidazoles as Anticancer Agents</title><author>Dende, Satheesh Kumar ; Korupolu, Raghu Babu ; Leleti, Krishnakanth Reddy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c849-55c8216b508bedb60065d54ca4da69852fe0f7355a4d60c54c5e61c902e3e8e73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dende, Satheesh Kumar</creatorcontrib><creatorcontrib>Korupolu, Raghu Babu</creatorcontrib><creatorcontrib>Leleti, Krishnakanth Reddy</creatorcontrib><collection>CrossRef</collection><jtitle>ChemistrySelect (Weinheim)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dende, Satheesh Kumar</au><au>Korupolu, Raghu Babu</au><au>Leleti, Krishnakanth Reddy</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Design and Synthesis of Sulfonamide‐Attached 2‐(Isoxazol‐3‐yl)‐1 H ‐imidazoles as Anticancer Agents</atitle><jtitle>ChemistrySelect (Weinheim)</jtitle><date>2020-07-15</date><risdate>2020</risdate><volume>5</volume><issue>26</issue><spage>7919</spage><epage>7922</epage><pages>7919-7922</pages><issn>2365-6549</issn><eissn>2365-6549</eissn><abstract>Library of 2‐(isoxazol‐3‐yl)‐1
H
‐imidazole sulfonamide derivatives
(4 a‐j)
has been synthesized and structures were confirmed by
1
HNMR,
13
CNMR and mass spectral analysis. Further these compounds were tested for their anticancer activity against four human cancer cell lines, such as MCF‐7 (breast cancer), A549 (lung cancer), Colo‐205 (colon cancer) and A2780 (ovarian cancer) by MTT assay and etoposide used as positive control. Among them, compounds
4 b
,
4 c
,
4 d
,
4 e
,
4 g
,
4 h
and
4 i
showed more potent anticancer activity against human cancer cell lines.</abstract><doi>10.1002/slct.202001449</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0003-3051-9949</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2365-6549 |
| ispartof | ChemistrySelect (Weinheim), 2020-07, Vol.5 (26), p.7919-7922 |
| issn | 2365-6549 2365-6549 |
| language | eng |
| recordid | cdi_crossref_primary_10_1002_slct_202001449 |
| source | Wiley Online Library All Journals |
| title | Design and Synthesis of Sulfonamide‐Attached 2‐(Isoxazol‐3‐yl)‐1 H ‐imidazoles as Anticancer Agents |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T21%3A53%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Design%20and%20Synthesis%20of%20Sulfonamide%E2%80%90Attached%202%E2%80%90(Isoxazol%E2%80%903%E2%80%90yl)%E2%80%901%20H%20%E2%80%90imidazoles%20as%20Anticancer%20Agents&rft.jtitle=ChemistrySelect%20(Weinheim)&rft.au=Dende,%20Satheesh%20Kumar&rft.date=2020-07-15&rft.volume=5&rft.issue=26&rft.spage=7919&rft.epage=7922&rft.pages=7919-7922&rft.issn=2365-6549&rft.eissn=2365-6549&rft_id=info:doi/10.1002/slct.202001449&rft_dat=%3Ccrossref%3E10_1002_slct_202001449%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |